Envestnet Asset Management
RVMD icon

Envestnet Asset Management’s Revolution Medicines RVMD Stock Holding History

Envestnet Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.7M Buy
30,450
+21,630
+245% +$3.16M ﹤0.01% 2371
2026
Q1 		$858K Buy
8,820
+4,744
+116% +$479K ﹤0.01% 3555
2025
Q4 		$325K Sell
4,076
-1,924
-32% -$126K ﹤0.01% 3979
2025
Q3 		$280K Sell
6,000
-123
-2% -$4.82K ﹤0.01% 4125
2025
Q2 		$225K Sell
6,123
-903
-13% -$34.7K ﹤0.01% 4178
2025
Q1 		$248K Sell
7,026
-4,399
-39% -$179K ﹤0.01% 4033
2024
Q4 		$500K Buy
11,425
+2,041
+22% +$103K ﹤0.01% 3581
2024
Q3 		$426K Buy
+9,384
New +$409K ﹤0.01% 3618

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Envestnet Asset Management's RVMD Position: Q2 2026 in Review

Envestnet Asset Management increased its Revolution Medicines (RVMD) stake by 245% in Q2 2026, buying an estimated $3.16M and bringing the position to 30,450 shares worth $5.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Envestnet Asset Management first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Envestnet Asset Management held 30,450 shares of Revolution Medicines worth $5.7M as of Q2 2026.
  • Envestnet Asset Management bought 21,630 Revolution Medicines shares in Q2 2026, an estimated $3.16M.
  • Revolution Medicines made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2371 holding.
  • Envestnet Asset Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.